The movement of IGF-I into the brain parenchyma after hypoxic-ischaemic injury

NeuroReport

Volumn 7, Issue 2, 1996, Pages 632-636

  Guan, Jian ^a   Skinner, Stephen J M ^a   Beilharz, Erica J ^a   Hua, Ke M ^b   Hodgkinson, Stephen ^b   Gluckman, Peter D ^a   Williams, Chris E ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b RUAKURA RESEARCH CENTRE   (New Zealand)

Author keywords

CSF; ECF; IGF I; injury; ischaemia; neurone; rat

Indexed keywords

NEUROPEPTIDE; SOMATOMEDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN INJURY; BRAIN VENTRICLE; CONTROLLED STUDY; CORPUS CALLOSUM; MALE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; RAT;

EID: 0029865402     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199601310-00061     Document Type: Article

References (24)

1. Pardridge WM. Transnasal and intraventricular delivery of drugs. In: Pardridge WM, eds. Peptide Drug Delivery to the Brain. New York: Raven Press, 1991: 98-122.
2. Lapchak PA, Araujo DM, Carswell S et al. Neuroscience 54, 445-460 (1993).
3. Guan J, Williams CE, Gunning M et al. J Cereb Blood Flow Metab 13, 609-616 (1993).
4. Galli C, Meucci O, Scorziello A et al. J Neurosci 15, 1172-1179 (1995).
5. Bailarz EJ, Williams CE, Dragunow M et al. Mol Brain Res 23, 1-14 (1995).
6. Gluckman PD, Klempt ND, Guan J et al. Blochem Biophys Res Commun 182, 593-599 (1992).
7. Means GE and Feeney RE. Selected techniques for the modification of protein side chains, In: Chemical Modification of Proteins. San Francisco: Holden-day, Inc, 1971: 214-230.
8. Breier BH, Gallaher BW, Milsom SR et al. Proc Endocr Soc Aust 33 (suppl), 48 (1990).
9. Boulware SD, Tamborlane WV, Matthews LS et al. Am J Physiol 262, E130-E133 (1992).
10. Hua KM, Hodgkinson SC and Bass JJ. JEndocrinol (In Press) (1995).
11. Fossasn G, Cavanagh ME, Evans CAN et al. Dev Brain Res 18, 113-124 (1985).
12. Dziegielewska K, Habgood M, Jones S et al. Comp Biochem Physiol (B) 92, 569-576 (1989).
13. Rennals ML, Blaumanis OR and Grady PA. Adv Neurol 52, 431-439 (1990).
14. Ohata K and Marmarou A. J Neurosurg 77, 387-396 (1982).
15. Ploeg V, Cintra A, Altiok N et al. Neuroscience 44, 205-214 (1991).
16. Preston E, Sutherland G and Finsten A. Neurosci Lett 149, 75-78 (1993).
17. Betz AL, Keep RF, Bear ME et al. J Cerebr Blood Flow Motab 14, 29-37 (1994).
18. Bergstadt K and Wieloch T. J Cerebr Blood Flow Metab 13, 895-898 (1993).
19. Sara VR, Carlsson Skwirut C, Drakenberg K et al. Proc NY Acad Sci 175, 24 (1992).
20. Rennels ML, Gregory T, Blaumanis OR et al. Brain Res 326, 47-63 (1986).
21. Blaumanis OR, Rennels ML and Grady PA. Adv Neurol 62, 386-389 (1990).
22. Sylvia AL, Seidler FJ and Slotkin TA. J Dev Physiol 12, 287-292 (1989).
23. Guan J. Williams CE, Mallard EC et al. Endocrinology (In Press) (1995).
24. Logan A, Gonzalez AM, Hill DJ et al. Endocrinology 135, 2265-2264 (1994).